Literature DB >> 19669820

Sexual dysfunction in women with obstructive sleep apnea.

Shyam Subramanian1, Swetha Bopparaju, Ashesh Desai, Tammy Wiggins, Cheryl Rambaud, Salim Surani.   

Abstract

BACKGROUND: Female sexual dysfunction is vastly under-recognized but has been previously described in chronic disease states. Sexual dysfunction in male patients with obstructive sleep apnea (OSA) is well described, but not in females.
OBJECTIVE: The objective of this study was to assess the prevalence of sexual dysfunction in women with OSA.
METHODS: We studied 21 consecutive pre-menopausal women with OSA, referred to our sleep lab, and who had a positive study for sleep apnea (respiratory disturbance index (RDI) > 5), and 11 healthy pre-menopausal women were included as the control group. Subjects were administered the Female Sexual Function Index (FSFI) questionnaire and a mood scale-Profile of Mood States.
RESULTS: Of the study group, 11 women (52.4%) had FSFI scores in the poor range (<23) as compared to the control group, in which none of the women (0%) had FSFI scores in the poor range (<23). Negative mood domain scores were not different in patients with poor FSFI compared to patients with normal FSFI scores. There was no correlation between obesity, severity of sleep apnea, or mood disorders on overall scores of sexual dysfunction. Among individual domains, there was a correlation between RDI and arousal scores.
CONCLUSION: In our study, we have found that prevalence of sexual dysfunction is high among women with OSA. Physicians should routinely screen and evaluate women with OSA for sexual dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19669820     DOI: 10.1007/s11325-009-0280-4

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  28 in total

Review 1.  Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature.

Authors:  I P Spector; M P Carey
Journal:  Arch Sex Behav       Date:  1990-08

2.  Does hypertension and its pharmacotherapy affect the quality of sexual function in women?

Authors:  L E Duncan; C Lewis; P Jenkins; T A Pearson
Journal:  Am J Hypertens       Date:  2000-06       Impact factor: 2.689

3.  Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment.

Authors:  M A Gonçalves; C Guilleminault; E Ramos; A Palha; T Paiva
Journal:  Sleep Med       Date:  2005-07       Impact factor: 3.492

4.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

5.  Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study.

Authors:  L Finn; T Young; M Palta; D G Fryback
Journal:  Sleep       Date:  1998-11-01       Impact factor: 5.849

6.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

Review 7.  Physiopathology of obstructive sleep apnea-hypopnea syndrome.

Authors:  Andrea Barral Martins; Sérgio Tufik; Sonia Maria Guimaraes Pereira Togeiro Moura
Journal:  J Bras Pneumol       Date:  2007 Jan-Feb       Impact factor: 2.624

8.  Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes.

Authors:  Paul Enzlin; Chantal Mathieu; Annick Van Den Bruel; Dirk Vanderschueren; Koen Demyttenaere
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

Review 9.  The impact of mental illness on sexual dysfunction.

Authors:  Zvi Zemishlany; Abraham Weizman
Journal:  Adv Psychosom Med       Date:  2008

10.  Does CPAP therapy improve erectile dysfunction in patients with obstructive sleep apnea syndrome?

Authors:  K Karkoulias; P Perimenis; N Charokopos; G Efremidis; F Sampsonas; A Kaparianos; D Patouchas; M Tsiamita; K Spiropoulos
Journal:  Clin Ter       Date:  2007 Nov-Dec
View more
  7 in total

1.  Association of sleep disturbance and sexual function in postmenopausal women.

Authors:  Juliana M Kling; JoAnn E Manson; Michelle J Naughton; M'hamed Temkit; Shannon D Sullivan; Emily W Gower; Lauren Hale; Julie C Weitlauf; Sara Nowakowski; Carolyn J Crandall
Journal:  Menopause       Date:  2017-06       Impact factor: 2.953

2.  Sleep Disorders in Postmenopausal Women.

Authors:  Shazia Jehan; Alina Masters-Isarilov; Idoko Salifu; Ferdinand Zizi; Girardin Jean-Louis; Seithikurippu R Pandi-Perumal; Ravi Gupta; Amnon Brzezinski; Samy I McFarlane
Journal:  J Sleep Disord Ther       Date:  2015-08-25

3.  Association of Continuous Positive Airway Pressure Treatment With Sexual Quality of Life in Patients With Sleep Apnea: Follow-up Study of a Randomized Clinical Trial.

Authors:  Sebastian M Jara; Martin L Hopp; Edward M Weaver
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-07-01       Impact factor: 6.223

4.  Long-term effects of continuous positive airway pressure treatment on sexuality in female patients with obstructive sleep apnea.

Authors:  Marian Petersen; Ellids Kristensen; Søren Berg; Bengt Midgren
Journal:  Sex Med       Date:  2013-12       Impact factor: 2.491

5.  Sexual function and distress in postmenopausal women with chronic insomnia: exploring the role of stress dysregulation.

Authors:  David A Kalmbach; Sheryl A Kingsberg; Thomas Roth; Philip Cheng; Cynthia Fellman-Couture; Christopher L Drake
Journal:  Nat Sci Sleep       Date:  2019-08-22

6.  Depression and obesity, but not mild obstructive sleep apnea, are associated factors for female sexual dysfunction.

Authors:  Glaury Coelho; Lia Bittencourt; Monica Levy Andersen; Thais Moura Guimarães; Luciana Oliveira E Silva; Gabriela Pontes Luz; Sergio Tufik; Helena Hachul
Journal:  Sleep Breath       Date:  2021-07-28       Impact factor: 2.816

7.  Obstructive sleep apnea and hormones - a novel insight.

Authors:  Marek Ruchała; Barbara Bromińska; Ewa Cyrańska-Chyrek; Barbara Kuźnar-Kamińska; Magdalena Kostrzewska; Halina Batura-Gabryel
Journal:  Arch Med Sci       Date:  2016-08-05       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.